Undervalued Drug Manufacturer Stocks on NAS February 2025

February 23, 2025

Drug Manufacturers

Drug Manufacturers are engaged in pharmaceutical manufacturing or sale of a diverse line of drug and healthcare products. This industry group also includes companies engaged in the development and discovery of new dugs, and tobacco and cannabis companies.

NASDAQ

The National Association of Securities Dealers Automated Quotations (Nasdaq) located in New York City, is the most active stock exchange by volume in the United States.

Our Valuation

A stock is considered undervalued if it trades at a discount to our valuation. To determine a stock’s intrinsic value, we developed an algorithm that uses 6 valuation models to determine the value of a company.* To learn more about stockcalc’s valuation methods, click here.

Undervalued Drug Manufacturers stocks

Stocks in this category are held primarily for potential income and capital appreciation.

For an in-depth look at the fundamentals and valuation of each company, try the stockcalc platform free for 30 days.

SymbolNameClose Price ($)Valuation ($)Difference (%)Average Vol (30D)Market Cap ($M)Yield (%)P/E Ratio
SBFM Sunshine Biopharma 2.45 7.09 189.58 51793 3 0.00 0.0
SXTC China SXT Pharmaceuticals 0.34 0.96 180.10 302526 0 0.00 0.0
SCLX Scilex Holding 0.33 0.92 175.90 1231301 42 0.00 0.0
PTPI Petros Pharma 0.12 0.33 169.23 8799630 1 0.00 0.0
UPC Universe Pharmaceuticals 0.20 0.46 128.79 31314844 0 0.00 0.0
EVOK Evoke Pharma 5.07 10.75 112.02 8573 7 0.00 0.0
AYTU Aytu BioPharma 1.35 2.70 99.87 29905 11 0.00 0.0
SHPH Shuttle Pharmaceuticals 0.59 1.14 92.35 48246 1 0.00 0.0
INM InMed Pharmaceuticals 3.17 6.00 89.44 92573 2 0.00 0.0
AMRN Amarin Corp 0.59 1.06 79.81 1094277 242 0.00 0.0
All data provided as at market close February 20, 2025.

Company Details

Sunshine Biopharma

SBFM:NAS

Close Price

2.45

Our Valuation

7.09

% Difference

189.58

Market Cap ($M)

3

P/E Ratio

0.0

Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. The company is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA targeted for liver cancer, (ii) SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections, and (iii) Adva-27a for pancreatic cancer.

Access the stockcalc valuation


China SXT Pharmaceuticals

SXTC:NAS

Close Price

0.34

Our Valuation

0.96

% Difference

180.10

Market Cap ($M)

0

P/E Ratio

0.0

China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.

Access the stockcalc valuation


Scilex Holding

SCLX:NAS

Close Price

0.33

Our Valuation

0.92

% Difference

175.90

Market Cap ($M)

42

P/E Ratio

0.0

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain.

Access the stockcalc valuation


Petros Pharma

PTPI:NAS

Close Price

0.12

Our Valuation

0.33

% Difference

169.23

Market Cap ($M)

1

P/E Ratio

0.0

Petros Pharmaceuticals Inc is a men's health pharmaceutical company. It focuses on therapeutics that promote medication adherence, tolerability, and preservation of male organic function. The company's operating segment includes Prescription Medications and Medical Devices. It generates maximum revenue from the Medical Devices segment. The Prescription Medications segment consists of operations related to vacuum erection devices, which are sold domestically and internationally.

Access the stockcalc valuation


Access our valuation for these companies and 9,000+ more

Try the stockcalc platform free for 30 days

Sign Up

Universe Pharmaceuticals

UPC:NAS

Close Price

0.20

Our Valuation

0.46

% Difference

128.79

Market Cap ($M)

0

P/E Ratio

0.0

Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies.

Access the stockcalc valuation


Evoke Pharma

EVOK:NAS

Close Price

5.07

Our Valuation

10.75

% Difference

112.02

Market Cap ($M)

7

P/E Ratio

0.0

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

Access the stockcalc valuation


Aytu BioPharma

AYTU:NAS

Close Price

1.35

Our Valuation

2.70

% Difference

99.87

Market Cap ($M)

11

P/E Ratio

0.0

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions.

Access the stockcalc valuation


Shuttle Pharmaceuticals

SHPH:NAS

Close Price

0.59

Our Valuation

1.14

% Difference

92.35

Market Cap ($M)

1

P/E Ratio

0.0

Shuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy.

Access the stockcalc valuation


InMed Pharmaceuticals

INM:NAS

Close Price

3.17

Our Valuation

6.00

% Difference

89.44

Market Cap ($M)

2

P/E Ratio

0.0

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids.

Access the stockcalc valuation


Amarin Corp

AMRN:NAS

Close Price

0.59

Our Valuation

1.06

% Difference

79.81

Market Cap ($M)

242

P/E Ratio

0.0

Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.

Access the stockcalc valuation


Access thousands of valuation reports

Try the stockcalc platform for 30 days for unlimited access to our valuation reports

Sign Up
Sunshine Biopharma and China SXT Pharmaceuticals are the most undervalued Drug Manufacturers stocks on the NAS. See the full list on the blog: https://www.stockcalc.com/Blog/undervalued-drug-manufacturer-stocks-nas-february-2025
Sunshine Biopharma $SBFM and China SXT Pharmaceuticals $SXTC are the most undervalued Drug Manufacturers stocks on the #NAS. See the full list: https://www.stockcalc.com/Blog/undervalued-drug-manufacturer-stocks-nas-february-2025
Sunshine Biopharma and China SXT Pharmaceuticals are the most undervalued Drug Manufacturers stocks on the NAS. See the full list on the blog: https://www.stockcalc.com/Blog/undervalued-drug-manufacturer-stocks-nas-february-2025

Copyright © 2016- Patchell Brook Equity Analytics Inc. All rights reserved.

Risk Disclosure: Equities trading and trading of all markets, exchanges and instruments contains substantial risk and is not for every investor. An investor could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing ones’ financial security or life style. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading. Past performance is not necessarily indicative of future results. View full risk information here.